# Daily-Level Associations Between PTSD and Cannabis Use Among Young Sexual Minority Women

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-use-anxiety-young-sexual-minority-women/
> **Published:** 2022-07-19T16:25:42-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:16:32-04:00
> **Clinical Summary:** Explore cannabis use and anxiety among young sexual minority women with PTSD, highlighting daily-level associations and substance use risks.

---

Sexual minority women (SMW, i.e. lesbian, bisexual, and other women who partner with women) experience trauma exposure and posttraumatic stress disorder (PTSD) more frequently than heterosexual women. They are also more prone to [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/), including cannabis consumption. However, few research has examined the relationships between PTSD and [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in this population.

The very first study focusing on this topic was conducted in 2017 by researchers at the University of Washington. This study included 90 self-identified sexual minority (34.4% lesbian and 48.9% bisexual) young adult women who suffered from trauma in the past. It evaluated the daily-level associations between their PTSD symptoms and cannabis uses. Participants were assessed at two measurement periods one year apart, each consisting of 14 consecutive daily assessments.

Several insights emerged. In total, [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) occurred on 22.8% of the days. A person’s level of PTSD symptom severity averaged over all assessed days was strongly associated with daily likelihood of cannabis use. In other words, among the young SMW surveyed, those with higher averaged PTSD scores over time had a higher likelihood of using cannabis on any given day. However, daily deviation from one’s average PTSD score was not associated with cannabis use on the same day.

That is, for a particular woman, the likelihood of cannabis use did not significantly increase on days she reported more PTSD symptoms than her average.

More research would be necessary to further elucidate the relationship between cannabis use and PTSD. However, it is already evident from the above preliminary study that the risk for cannabis use and abuse should be a consideration when intervention strategies for SMW with PTSD are developed.

[More access here](https://cedclinic.com/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Kaiser Study Finds Higher Risk of Psychiatric Disorders in Teens Who Use Cannabis](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/)

This study highlights the increased psychiatric risks linked to [cannabis use in teens](https://cedclinic.com/stress-cannabis-use-adolescents-covid19-impact/), providing context for mental health concerns in young populations.

[Read More](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/)

[Endocannabinoid System Research: Trauma and Substance Use](https://cedclinic.com/pre-trauma-insomnia-alcohol-cannabis-risk/)

Explore how the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) interacts with trauma and [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/), offering insights relevant to PTSD and [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/).

[Explore Research](https://cedclinic.com/pre-trauma-insomnia-alcohol-cannabis-risk/)

[Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News](https://cedclinic.com/cannabis-use-mental-health-risks-canada-study/)

A recent study discusses the rising trends of cannabis use alongside anxiety and depression, underscoring the importance of mental health awareness.

[Learn More](https://cedclinic.com/cannabis-use-mental-health-risks-canada-study/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Daily-Level%20Associations%20Between%20PTSD%20and%20Cannabis%20Use%20Among%20Young%20Sexual%20Minority%20Women&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-anxiety-young-sexual-minority-women%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-anxiety-young-sexual-minority-women%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Daily-Level%20Associations%20Between%20PTSD%20and%20Cannabis%20Use%20Among%20Young%20Sexual%20Minority%20Women%20https%3A%2F%2Fcedclinic.com%2Fcannabis-use-anxiety-young-sexual-minority-women%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
